Education
Medical School: American University of Beirut, Residency: Good Samaritan Hospital of Maryland, affiliated with the Johns Hopkins Univ. Baltimore, MD, USA, Fellowship:Fellowship in Hematology & Medical Oncology - University of Miami/Jackson Memorial & Sylvester Comprehensive Cancer Center, Miami, FL, USA
Research & Clinical Interest
1- Kharfan-Dabaja MA, Chavez JC, Yu D, Zhu W, Fernandez-Vertiz EI, Perkins J, Shapiro J, Bookout R, Perez L, Fernandez HF, Komrokji RS, Lancet J, Brand L, Field T, Ayala E, Janssen W, List AF, Anasetti C. Severe hypoalbuminemia at day 90 predicts worse non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant. 2010 Jul 21. [Epub ahead of print]
2- Kharfan-Dabaja MA, Bazarbachi A. Emerging role of CD20 blockade in allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010; 16: 1347-1354. [Epub ahead of print, Jan 15, 2010]
3- Hoda D, Pidala J, Salgado-Vila N, Kim J, Perkins J, Bookout R, Field T, Perez L, Ayala E, Ochoa-Bayona JL, Raychaudhuri J, Alsina M, Greene J, Janssen W, Fernandez HF, Anasetti C, Kharfan-Dabaja MA. Sirolimus for treatment of steroid-refractory acute graft-versus-host disease (aGVHD). Bone Marrow Transplant. 2010; 45(8):1347-51. [Epub ahead of print 2009 Dec 7].
4- Kharfan-Dabaja MA, Mhaskar AR, Djulbegovic B, Cutler C, Mohty M, Kumar A. Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis. Biol. Blood Marrow Transplant. 2009; 15(9): 1005-1013.
5- Kharfan-Dabaja MA, Chavez JC, Khorfan KA, Pinilla-Ibarz J. Clinical and Therapeutic Implications of the Mutational Status of IgVH in Patients with Chronic Lymphocytic Leukemia. Cancer. 2008; 113: 897-906.
